Cover Image
市場調查報告書

幽門螺旋桿菌感染疾病:全球臨床實驗趨勢

Helicobacter Pylori Infections Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 172360
出版日期 內容資訊 英文 77 Pages
訂單完成後即時交付
價格
Back to Top
幽門螺旋桿菌感染疾病:全球臨床實驗趨勢 Helicobacter Pylori Infections Global Clinical Trials Review, H1, 2015
出版日期: 2015年06月16日 內容資訊: 英文 77 Pages
簡介

本報告提供幽門螺旋桿菌感染疾病臨床實驗相關之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,實驗對像採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 幽門螺旋桿菌感染疾病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:感染疾病治療藥臨床實驗上幽門螺旋桿菌感染疾病的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病治療藥臨床實驗上幽門螺旋桿菌感染疾病的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

幽門螺旋桿菌感染疾病臨床實驗的主要參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • RedHill Biopharma Ltd.
    • AstraZeneca Plc
    • MerLion Pharmaceuticals Pte Ltd
    • Aspen Pharmacare Holdings Ltd
    • 武田藥品工業
    • 大塚集團
    • Eisai
    • Forest Laboratories, Inc.
    • Chemo Espana, S.A.
    • Bluefish Pharmaceuticals AB
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Taiwan University Hospital
    • Tehran University of Medical Sciences
    • Mazandaran University of Medical Sciences
    • 慶應大學
    • Shanghai Jiao Tong University School of Medicine
    • Buddhist Tzu Chi General Hospital
    • Guilan University of Medical Sciences
    • Kaohsiung Veterans General Hospital.
    • 東京大學醫學系附屬醫院
    • National Cancer Center

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2732CTIDB

GlobalData's clinical trial report, "Helicobacter Pylori Infections Global Clinical Trials Review, H1, 2015" provides an overview of Helicobacter Pylori Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Helicobacter Pylori Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Helicobacter Pylori Infections
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Helicobacter Pylori Infections
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Helicobacter Pylori Infections Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Helicobacter Pylori Infections
      • Jun 08, 2015: RedHill Biopharma Completes Treatment of Last Patient with RHB-105 in Phase III Study
      • Jun 03, 2015: RedHill Biopharma Provides Update on Development Pipeline and Expected Timing for RHB-105 Phase III Top-Line Results
      • May 07, 2015: RedHill Biopharma to Host Investor Webcast Forum Following Completion of RHB-105 Dosing in Phase III Study
      • Apr 27, 2015: RedHill Biopharma Announces Completion of Patient Enrollment in a Phase III Study of RHB-105 for H. pylori Infection
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • RedHill Biopharma Ltd.
      • Clinical Trial Overview of RedHill Biopharma Ltd.
      • AstraZeneca Plc
      • Clinical Trial Overview of AstraZeneca Plc
      • MerLion Pharmaceuticals Pte Ltd
      • Clinical Trial Overview of MerLion Pharmaceuticals Pte Ltd
      • Aspen Pharmacare Holdings Ltd
      • Clinical Trial Overview of Aspen Pharmacare Holdings Ltd
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Otsuka Holdings Co., Ltd.
      • Clinical Trial Overview of Otsuka Holdings Co., Ltd.
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • Forest Laboratories, Inc.
      • Clinical Trial Overview of Forest Laboratories, Inc.
      • Chemo Espana, S.A.
      • Clinical Trial Overview of Chemo Espana, S.A.
      • Bluefish Pharmaceuticals AB
      • Clinical Trial Overview of Bluefish Pharmaceuticals AB
    • Clinical Trial Overview of Top Institutes / Government
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • Mazandaran University of Medical Sciences
      • Clinical Trial Overview of Mazandaran University of Medical Sciences
      • Keio University
      • Clinical Trial Overview of Keio University
      • Shanghai Jiao Tong University School of Medicine
      • Clinical Trial Overview of Shanghai Jiao Tong University School of Medicine
      • Buddhist Tzu Chi General Hospital
      • Clinical Trial Overview of Buddhist Tzu Chi General Hospital
      • Guilan University of Medical Sciences
      • Clinical Trial Overview of Guilan University of Medical Sciences
      • Kaohsiung Veterans General Hospital.
      • Clinical Trial Overview of Kaohsiung Veterans General Hospital.
      • The University of Tokyo Hospital
      • Clinical Trial Overview of The University of Tokyo Hospital
      • National Cancer Center
      • Clinical Trial Overview of National Cancer Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials by Region, 2015*
  • Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Helicobacter Pylori Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Helicobacter Pylori Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Helicobacter Pylori Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Helicobacter Pylori Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Helicobacter Pylori Infections Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Helicobacter Pylori Infections Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Helicobacter Pylori Infections Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Helicobacter Pylori Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by RedHill Biopharma Ltd., 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by MerLion Pharmaceuticals Pte Ltd, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Aspen Pharmacare Holdings Ltd, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Chemo Espana, S.A., 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Mazandaran University of Medical Sciences, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Jiao Tong University School of Medicine, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Buddhist Tzu Chi General Hospital, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Guilan University of Medical Sciences, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaohsiung Veterans General Hospital., 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center, 2015*

List of Figures

  • Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Helicobacter Pylori Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Helicobacter Pylori Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Helicobacter Pylori Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Helicobacter Pylori Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Helicobacter Pylori Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Helicobacter Pylori Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Helicobacter Pylori Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top